A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke

被引：0
|
作者：
Kasner, Scott E. [1 ,2 ]
Levine, Steven R. [3 ,4 ,5 ]
机构：
[1] Univ Penn, Med Ctr, Stroke Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
[3] SUNY Hlth Sci Ctr, Stroke Ctr, Brooklyn, NY 11203 USA
[4] SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA
[5] Sch Med, Brooklyn, NY 11203 USA
来源：
LANCET NEUROLOGY | 2010年 / 9卷 / 09期
关键词：
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; THROMBOLYSIS; TIME;
D O I：
10.1016/S1474-4422(10)70169-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：843 / 845
页数：3
相关论文
共 50 条
  • [31] Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke
    Ehlers, Lars
    Andersen, Grethe
    Clausen, Lone Beltoft
    Bech, Merete
    Kjolby, Mette
    STROKE, 2007, 38 (01) : 85 - 89
  • [32] Practice diversity among US stroke physicians with respect to the 3-to 4.5-h window
    Mutgi, Sunil A.
    Behrouz, Reza
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (03) : E24 - E25
  • [33] Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
    Bluhmki, Erich
    Chamorro, Angel
    Davalos, Antoni
    Machnig, Thomas
    Sauce, Christophe
    Wahlgren, Nils
    Wardlaw, Joanna
    Hacke, Werner
    LANCET NEUROLOGY, 2009, 8 (12): : 1095 - 1102
  • [34] Safety And Outcome of IV Thrombolysis in Patients with Acute Stroke Treated In the 3-4.5 h Window Who Would Have Been Excluded From The ECASS III Trial
    Farrag, Abeer B.
    Sahota, Preeti
    Grotta, James
    Savitz, Sean
    STROKE, 2011, 42 (03) : E137 - E137
  • [35] Risk factors and a model for prognosis prediction after intravenous thrombolysis with alteplase in acute ischemic stroke based on propensity score matching
    Huang, Pan
    Yi, XingYang
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2024, 38
  • [36] Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan
    Miyamoto, Yoshihisa
    Aso, Shotaro
    Iwagami, Masao
    Morita, Kojiro
    Fushimi, Kiyohide
    Hamasaki, Yoshifumi
    Nangaku, Masaomi
    Doi, Kent
    Yasunaga, Hideo
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (12):
  • [37] Intravenous thrombolysis beyond the 3h time window after stroke onset and in stroke patients after 80 years and older
    Neundoerfer, B.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2007, 75 (06) : 315 - 316
  • [38] Thrombolysis with alteplase 3-4•5 h after acute ischaemic stroke (SITS-ISTR):: an observational study
    Wahlgren, Nils
    Ahmed, Niaz
    Davalos, Antoni
    Hacke, Werner
    Millan, Monica
    Muir, Keith
    Roine, Risto O.
    Toni, Danilo
    Lees, Kennedy R.
    LANCET, 2008, 372 (9646): : 1303 - 1309
  • [39] MRI based thrombolysis for FLAIR-negative stroke patients within 4.5-6 h after symptom onset
    Wei, Xiao-Er
    Zhou, Jia
    Li, Wen-Bin
    Zhao, Yu-Wu
    Li, Ming-Hua
    Li, Yue-Hua
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 372 : 421 - 427
  • [40] Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
    Davis, Stephen M.
    Donnan, Geoffrey A.
    Parsons, Mark W.
    Levi, Christopher
    Butcher, Kenneth S.
    Peeters, Andre
    Barber, P. Alan
    Bladin, Christopher
    De Silva, Deidre A.
    Byrnes, Graham
    Chalk, Jonathan B.
    Fink, John N.
    Kimber, Thomas E.
    Schultz, David
    Hand, Peter J.
    Frayne, Judith
    Hankey, Graeme
    Muir, Keith
    Gerraty, Richard
    Tress, Brian M.
    Desmond, Patricia M.
    LANCET NEUROLOGY, 2008, 7 (04): : 299 - 309
12345